BioAge Labs (BIOA) Payables (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Payables data on file, last reported at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 23.14% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (down 23.14% YoY), and the FY2025 full-year result was $2.7 million, up 33.97% from the prior year.
• Payables grew to $3.1 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Payables ranged from a high of $5.0 million in Q3 2025 to a low of $1.3 million in Q2 2025.
• A 4-year average of $2.8 million and a median of $2.4 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables jumped 139.18% in 2025 and slipped 23.14% in 2026, its largest moves.
• Tracing BIOA's Payables over 4 years: stood at $1.9 million in 2023, then gained by 6.97% to $2.0 million in 2024, then surged by 33.97% to $2.7 million in 2025, then grew by 14.66% to $3.1 million in 2026.
• Business Quant data shows BIOA's Payables at $3.1 million in Q1 2026, $2.7 million in Q4 2025, and $5.0 million in Q3 2025.